𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of immunisation with a recombinant yeast-derived hepatitis B vaccine

✍ Scribed by W. Jilg; F. Deinhardt

Book ID
108405885
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
250 KB
Volume
13
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparative evaluation of the immunogeni
Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants
✍ Subrat K. Panda; Rajagopal Ramesh; Kanury V. S. Rao; Asha Gupta; Arie J. Zuckerm πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

## Abstract The immunogenicity of plasma‐derived (HB Vax, MSD) and recombinant hepatitis B virus (Engerix B, SKF) vaccines was evaluated in infants born to hepatitis B virus carrier mothers. The vaccination was carried out at 1 day, 1 month, and 6 months of age using 10 ΞΌg of the vaccine given intr

Immunogenicity of a yeast-recombinant he
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children
✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta

Recombinant-yeast-derived hepatitis b va
Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine
✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis